TITLE

GnRHa to trigger final oocyte maturation: a time to reconsider

AUTHOR(S)
Humaidan, P.; Papanikolaou, E. G.; Tarlatzis, B. C.
PUB. DATE
October 2009
SOURCE
Human Reproduction;Oct2009, Vol. 24 Issue 10, p2389
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recently GnRH antagonist protocols for the prevention of a premature LH surge were introduced, allowing final oocyte maturation to be triggered with a single bolus of a GnRH agonist (GnRHa). GnRHa is as effective as hCG for the induction of ovulation, and apart from the LH surge a FSH surge is also induced. Until recently, prospective randomized studies reported a poor clinical outcome when GnRHa was used to trigger final oocyte maturation in IVF/ICSI antagonist protocols, presumably due to a luteal phase deficiency, despite standard luteal phase supplementation with progesterone and estradiol. As GnRHa triggering of final oocyte maturation could possess advantages over hCG triggering in terms of a reduced if not eliminated risk of ovarian hyperstimulation syndrome (OHSS) and the retrieval of more mature oocytes, the challenge has been to rescue the luteal phase. In the literature now several studies report a luteal phase rescue with a reproductive outcome comparable to that of hCG induced final oocyte maturation. Although more research is needed, GnRHa triggering is now a valid alternative with potential benefits.
ACCESSION #
44558348

 

Related Articles

  • Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger. Kummer, N.E.; Feinn, R.S.; Griffin, D.W.; Nulsen, J.C.; Benadiva, C.A.; Engmann, L.L. // Human Reproduction;Jan2013, Vol. 28 Issue 1, p152 

    STUDY QUESTION Are there factors predicting the number of total and mature oocytes retrieved after controlled ovarian hyperstimulation (COH) utilizing a gonadotropin-releasing hormone (GnRH) antagonist protocol and a GnRH agonist (GnRHa) to induce oocyte maturation? SUMMARY ANSWER Peak estradiol...

  • HCG: Is it the Best Choice for Ovulation Triggering? Humaidan, Peter; Bodri, Daniel; Papanikolaou, Evangelos G.; Kol, Shahar // Open Reproductive Science Journal;2012, Vol. 4, p1 

    With the increasing use of gonadotropin releasing hormone antagonist protocols, it has become an option to trigger ovulation with gonadotropin releasing hormone agonist which has several advantages over human chorionic gonadotropin triggering; among those an elimination or reduction in ovarian...

  • GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Humaidan, P.; Kol, S.; Papanikolaou, EG. // Human Reproduction Update;Jul2011, Vol. 17 Issue 4, p510 

    BACKGROUND GnRH agonist (GnRHa) triggering has been shown to significantly reduce the occurrence of ovarian hyperstimulation syndrome (OHSS) compared with hCG triggering; however, initially a poor reproductive outcome was reported after GnRHa triggering, due to an apparently uncorrectable luteal...

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

  • Gonadotropin-releasing hormone-agonist induces apoptosis of human granulosa-luteal cells via caspase-8, -9 and -3, and poly- (ADP-ribose)-polymerase cleavage. Eun Joo Park; Jung Whan Shin; Yong Soo Seo; Dae Wun Kim; Seo Yoo Hong; Won Il Park; Byung Moon Kang // BioScience Trends;Jun2011, Vol. 5 Issue 3, p120 

    Gonadotropin-releasing hormone-agonist (GnRH-Ag) used in controlled ovarian hyperstimulation (COH) for in vitro fertilization and embryo transfer (IVF-ET) has been known to directly affect apoptosis of human ovarian cells, but its mechanism is not clearly understood. Therefore, the purpose of...

  • Effects of Prolonged Desensitization in a Standardized Long GnRHa Protocol.  // Fertility Weekly;2/27/2012, p9 

    The article offers information on the study conducted by the state researchers in France on the effects of prolonged desensitization in a standardized long gonadotropin-releasing hormone (GnRH) agonist protocol. It notes the application of prolong desensitization for the accomplishment of...

  • Buserelin/chorionic gonadotropin/triptorelin.  // Reactions Weekly;9/21/2013, Issue 1470, p12 

    An abstract of the article "Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addtion of 1500 IU hCG," by A. Seyhan and colleagues is presented.

  • ADJUNCTS FOR COH -- METFORMIN, GROWTH HORMONE, ANDROGENS AND MORE. Meldrum, D. R. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Oct2010 S3 Supplemen, Vol. 20, pS96 

    Introduction: There are numerous adjuncts to controlled ovarian stimulation (COS) that increase the effectiveness or reduce complications of COS. Materials/Methods: Twelve adjuncts will be reviewed, including evidence of efficacy, supporting research, mechanisms of action, recommended regimens,...

  • Clinical Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Undergoing ART Cycles. Davar, Robab; Aflatoonian, Abbas; Asgharnia, Maryam // Acta Medica Iranica;2009, Vol. 47 Issue 4, p263 

    The microdose GnRH agonist (GnRH-a) flare protocol may have a particular value for previously poor responders in whom it has been observed to stimulate dramatic increases in serum FSH. The Purpose of this study was to determine the effects of microdose GnRH-a in poor responders. This is a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics